,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,1189,1,5,,48413942,440917,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results,Other,,
1,1194,1,3,,48413942,440917,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity,Other,,
2,1199,1,3,,48413942,440917,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Mouse Bioassay Results,Other,,
3,1208,1,3,,48413942,440917,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results,Other,,
4,19262,5,1,,103581572,440917,Unspecified,,,,,Aqueous solubility,Other,10866370.0,
5,302171,6,2,,103581572,440917,Unspecified,,,66.0,IC50,Antiplasmodial activity after 48 hrs against chloroquine-resistant Plasmodium falciparum FcM29-Cameroon by [3H]hypoxanthine uptake,Confirmatory,17904365.0,
6,302172,6,2,,103581572,440917,Unspecified,,,,,Antifungal activity against Candida albicans ATCC 90028 after 48 hrs,Other,17904365.0,
7,302173,6,2,,103581572,440917,Unspecified,,,,,Antifungal activity against Candida albicans ATCC 90028 after 24 hrs,Other,17904365.0,
8,332912,9,1,,103581572,440917,Unspecified,,,,,Antimicrobial activity Propionibacterium acnes ATCC 11827 after 2 days by broth dilution method,Other,8158169.0,
9,334989,6,3,,103581572,440917,Unspecified,,,,,Antimicrobial activity against Bacillus subtilis ATCC 9372 after 2 days by twofold serial broth dilution method,Other,1517735.0,
10,334990,6,3,,103581572,440917,Unspecified,,,,,Antimicrobial activity against Brevibacterium ammoniagenes ATCC 6872 after 2 days by twofold serial broth dilution method,Other,1517735.0,
11,334991,6,3,,103581572,440917,Unspecified,,,,,Antimicrobial activity against Propionibacterium acnes ATCC 11827 after 2 days by twofold serial broth dilution method,Other,1517735.0,
12,334992,6,3,,103581572,440917,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus ATCC 12598 after 2 days by twofold serial broth dilution method,Other,1517735.0,
13,334993,6,3,,103581572,440917,Unspecified,,,,,Antimicrobial activity against Streptococcus mutans ATCC 25175 after 2 days by twofold serial broth dilution method,Other,1517735.0,
14,334994,6,3,,103581572,440917,Unspecified,,,,,Antimicrobial activity against Escherichia coli ATCC 9637 after 2 days by twofold serial broth dilution method,Other,1517735.0,
15,334995,6,3,,103581572,440917,Unspecified,,,,,Antimicrobial activity against Pseudomonas aeruginosa ATCC 10145 after 2 days by twofold serial broth dilution method,Other,1517735.0,
16,334996,6,3,,103581572,440917,Unspecified,,,,,Antimicrobial activity against Enterobacter aerogenes ATCC 13048 after 2 days by twofold serial broth dilution method,Other,1517735.0,
17,334997,6,3,,103581572,440917,Unspecified,,,,,Antimicrobial activity against Saccharomyces cerevisiae ATCC 7754 after 2 days by twofold serial broth dilution method,Other,1517735.0,
18,334998,6,3,,103581572,440917,Unspecified,,,,,Antimicrobial activity against Candida utilis ATCC 9226 after 2 days by twofold serial broth dilution method,Other,1517735.0,
19,334999,6,3,,103581572,440917,Unspecified,,,,,Antimicrobial activity against Pityrosporum ovale ATCC 14521 by twofold serial broth dilution method,Other,1517735.0,
20,335000,6,3,,103581572,440917,Unspecified,,,,,Antimicrobial activity against Penicillium chrysogenum ATCC 10106 after 5 days by twofold serial broth dilution method,Other,1517735.0,
21,336478,3,7,,103581572,440917,Unspecified,,,,,Inhibition of COX2 at 100 uM by scintillation proximity assay,Other,12444669.0,
22,338297,3,4,,103581572,440917,Unspecified,,,,,Acaricidal activity against Psoroptes cuniculi at 1% dilution in physiological saline after 48 hrs by direct contact assay,Other,7595592.0,
23,338298,3,4,,103581572,440917,Unspecified,,,,,Acaricidal activity against Psoroptes cuniculi at 0.25% dilution in physiological saline after 48 hrs by direct contact assay,Other,7595592.0,
24,338299,3,4,,103581572,440917,Unspecified,,,,,Acaricidal activity against Psoroptes cuniculi at 0.125% dilution in physiological saline after 48 hrs by direct contact assay,Other,7595592.0,
25,338300,3,4,,103581572,440917,Unspecified,,,,,Acaricidal activity against Psoroptes cuniculi at 6 uL after 24 hrs by inhalation assay,Other,7595592.0,
26,338301,3,4,,103581572,440917,Unspecified,,,,,Acaricidal activity against Psoroptes cuniculi at 3 uL after 24 hrs by inhalation assay,Other,7595592.0,
27,338302,3,4,,103581572,440917,Unspecified,,,,,Acaricidal activity against Psoroptes cuniculi at 1 uL after 24 hrs by inhalation assay,Other,7595592.0,
28,433903,3,3,,103581572,440917,Unspecified,,,,,Hepatotoxicity in mouse assessed as carcinogenic potency,Other,19272677.0,
29,477768,5,2,,103581572,440917,Unspecified,,,185.0,IC50,Antileishmanial activity against Leishmania sp. by MTT assay,Confirmatory,20116908.0,
30,477769,5,2,,103581572,440917,Unspecified,,,876.2,IC50,Antileishmanial activity against Leishmania (Viannia) braziliensis promastigotes,Confirmatory,20116908.0,
31,477773,3,3,,103581572,440917,Unspecified,,,,,Antitrypanosomal activity against Trypanosoma cruzi Tulahuen 2 assessed as inhibition of epimastigotes growth at 50 uM,Other,20116908.0,
32,477774,5,2,,103581572,440917,Unspecified,,,50.0,IC50,Antitrypanosomal activity against Trypanosoma cruzi Tulahuen 2 assessed as inhibition of epimastigotes growth,Confirmatory,20116908.0,
33,588209,2,3,,103581572,440917,Unspecified,,,,,Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset,Other,20553011.0,
34,588210,2,4,,103581572,440917,Unspecified,,,,,Human drug-induced liver injury (DILI) modelling dataset from Ekins et al,Other,20843939.0,
35,651631,4,1,,144207598,440917,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
36,651632,4,1,,144207598,440917,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
37,651633,4,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
38,651634,4,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
39,654517,1,2,,103581572,440917,Inactive,,,,,"Binding affinity to 1,2-dimyristoyl-sn-glycero-3-phosphocholine bilayer assessed as change in main phase transition temperature at low concentration by differential scanning calorimetry",Other,22272932.0,
40,654518,1,2,,103581572,440917,Unspecified,,,,,"Binding affinity to 1,2-dimyristoyl-sn-glycero-3-phosphocholine bilayer assessed as decrease in main phase transition temperature at high concentration by differential scanning calorimetry (Rvb = 24.4 deg C)",Other,22272932.0,
41,654519,3,1,,103581572,440917,Unspecified,,,,,"1,2-dimyristoyl-sn-glycero-3-phosphocholine bilayer-water partition coefficient, K of the compound at 300 uM by isothermal titration calorimetry at 35 deg C",Other,22272932.0,
42,654520,1,2,,103581572,440917,Unspecified,,,,,"Binding affinity to 1,2-dimyristoyl-sn-glycero-3-phosphocholine bilayer assessed as increase in pre-transition temperature at low concentration by differential scanning calorimetry (Rvb = 12.7 deg C)",Other,22272932.0,
43,654521,1,2,,103581572,440917,Inactive,,,,,"Binding affinity to Me-5-DSA labelled 1,2-dimyristoyl-sn-glycero-3-phosphocholine bilayer containing assessed as change in membrane fluidity by electron paramagnetic resonance spectroscopy",Other,22272932.0,
44,654522,1,2,,103581572,440917,Inactive,,,,,"Binding affinity to Me-16-DSA labelled 1,2-dimyristoyl-sn-glycero-3-phosphocholine bilayer containing assessed as change in membrane fluidity by electron paramagnetic resonance spectroscopy",Other,22272932.0,
45,654523,1,2,,103581572,440917,Inactive,,,,,"Binding affinity to 5-DSA labelled 1,2-dimyristoyl-sn-glycero-3-phosphocholine bilayer containing assessed as change in membrane fluidity by electron paramagnetic resonance spectroscopy",Other,22272932.0,
46,654524,1,2,,103581572,440917,Inactive,,,,,"Binding affinity to CSL labelled 1,2-dimyristoyl-sn-glycero-3-phosphocholine bilayer containing assessed as change in membrane fluidity by electron paramagnetic resonance spectroscopy",Other,22272932.0,
47,659295,1,3,,103581572,440917,Unspecified,,,,,Antimycoplasmal activity against Mycoplasma hominis PG21 after 24 to 48 hrs by broth microdilution method,Other,22465092.0,
48,659296,1,3,,103581572,440917,Unspecified,,,,,Antimycoplasmal activity against Mycoplasma fermentans Pg18 after 24 to 48 hrs by broth microdilution method,Other,22465092.0,
49,659297,1,3,,103581572,440917,Unspecified,,,,,Antimycoplasmal activity against Mycoplasma pneumoniae K7 after 3 to 5 days by broth microdilution method,Other,22465092.0,
50,720516,2,1,,144207598,440917,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
51,720552,2,1,,144207598,440917,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
52,720634,2,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
53,720635,2,1,,144207598,440917,Inconclusive,,,68.5199,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
54,720637,2,1,,144207598,440917,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
55,720674,2,2,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
56,720675,2,2,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
57,720678,2,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
58,720679,2,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
59,720680,2,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
60,720681,2,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
61,720682,2,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
62,720683,2,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
63,720684,2,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
64,720685,2,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
65,720686,2,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
66,720687,2,2,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
67,720691,4,1,,144207598,440917,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
68,720692,3,1,,144207598,440917,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
69,720693,3,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
70,720719,2,1,,144207598,440917,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
71,720725,2,1,,144207598,440917,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
72,743012,3,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
73,743014,3,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
74,743015,3,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
75,743033,3,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
76,743035,2,1,,144207598,440917,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
77,743036,2,1,,144207598,440917,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
78,743040,3,1,,144207598,440917,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
79,743041,3,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
80,743042,3,1,,144207598,440917,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
81,743053,2,1,,144207598,440917,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
82,743054,2,1,,144207598,440917,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
83,743063,2,1,,144207598,440917,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
84,743064,3,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
85,743065,3,1,,144207598,440917,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
86,743066,3,1,,144207598,440917,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
87,743067,2,1,,144207598,440917,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
88,743069,2,1,,144207598,440917,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
89,743074,2,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
90,743075,2,1,,144207598,440917,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
91,743077,2,1,,144207598,440917,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
92,743078,2,1,,144207598,440917,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
93,743079,3,1,,144207598,440917,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
94,743080,3,1,,144207598,440917,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
95,743081,3,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
96,743083,3,1,,144207598,440917,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
97,743084,3,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
98,743085,3,1,,144207598,440917,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
99,743086,3,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
100,743091,2,1,,144207598,440917,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
101,743094,3,1,,144207598,440917,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
102,743122,2,1,,144207598,440917,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
103,743139,2,1,,144207598,440917,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
104,743140,2,1,,144207598,440917,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
105,743191,3,1,,144207598,440917,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
106,743194,3,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
107,743199,2,1,,144207598,440917,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
108,743202,4,1,,144207598,440917,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
109,743203,3,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
110,743209,3,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
111,743210,4,1,,144207598,440917,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
112,743211,3,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
113,743212,3,1,,144207598,440917,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
114,743213,3,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
115,743215,3,1,,144207598,440917,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
116,743217,3,1,,144207598,440917,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
117,743218,3,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
118,743219,3,1,,144207598,440917,Inactive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
119,743220,3,1,,144207598,440917,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
120,743221,3,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
121,743222,3,1,,144207598,440917,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
122,743223,3,1,,144207598,440917,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
123,743224,3,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
124,743225,3,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
125,743226,2,1,,144207598,440917,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
126,743227,2,1,,144207598,440917,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
127,743228,3,1,,144207598,440917,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
128,743239,2,1,,144207598,440917,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
129,743240,2,1,,144207598,440917,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
130,743241,2,1,,144207598,440917,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
131,743242,2,1,,144207598,440917,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
132,925905,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: R040729,Other,,
133,925906,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: R040729,Other,,
134,925907,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: R040729,Other,,
135,925908,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: R040729,Other,,
136,925909,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: R040729,Other,,
137,925910,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: R040729,Other,,
138,926538,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: R040729,Other,,
139,926539,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: R040729,Other,,
140,926540,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: R040729,Other,,
141,926541,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: R040729,Other,,
142,926542,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: R040729,Other,,
143,926543,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: R040729,Other,,
144,926544,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: R040729,Other,,
145,929798,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: R040729,Other,,
146,929799,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: R040729,Other,,
147,930427,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: R040729,Other,,
148,932443,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: R040729,Other,,
149,932444,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: R040729,Other,,
150,932445,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: R040729,Other,,
151,932446,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: R040729,Other,,
152,932447,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: R040729,Other,,
153,932448,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: R040729,Other,,
154,932449,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: R040729,Other,,
155,932450,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: R040729,Other,,
156,932451,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: R040729,Other,,
157,932452,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: R040729,Other,,
158,965970,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: R040729,Other,,
159,965971,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: R040729,Other,,
160,965972,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: R040729,Other,,
161,965973,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: R040729,Other,,
162,965974,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: R040729,Other,,
163,965975,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: R040729,Other,,
164,965976,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CK (Creatine Kinase); Study_ID: R040729,Other,,
165,965977,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: R040729,Other,,
166,965978,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: R040729,Other,,
167,965979,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: R040729,Other,,
168,965980,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: R040729,Other,,
169,965981,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CO2 (Carbon Dioxide); Study_ID: R040729,Other,,
170,965982,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: R040729,Other,,
171,965983,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: LIPASE (Triacylglycerol Lipase); Study_ID: R040729,Other,,
172,965984,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: R040729,Other,,
173,965985,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: R040729,Other,,
174,965986,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: URATE (Urate); Study_ID: R040729,Other,,
175,966419,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: R040729,Other,,
176,966420,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: R040729,Other,,
177,972922,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CO2 (Carbon Dioxide); Study_ID: R040729,Other,,
178,972923,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: LIPASE (Triacylglycerol Lipase); Study_ID: R040729,Other,,
179,972924,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: R040729,Other,,
180,972925,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: URATE (Urate); Study_ID: R040729,Other,,
181,972926,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: R040729,Other,,
182,972927,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CK (Creatine Kinase); Study_ID: R040729,Other,,
183,972928,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: R040729,Other,,
184,972929,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: R040729,Other,,
185,972930,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: R040729,Other,,
186,972931,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: R040729,Other,,
187,972932,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: R040729,Other,,
188,972933,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: R040729,Other,,
189,972934,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: R040729,Other,,
190,973566,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: R040729,Other,,
191,973567,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: R040729,Other,,
192,973568,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: R040729,Other,,
193,973569,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: R040729,Other,,
194,973570,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: R040729,Other,,
195,973571,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: R040729,Other,,
196,1016306,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Epicardium, Cellular Infiltrate, Mixed Cell; Study_ID: R040729",Other,,
197,1016307,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Epicardium, Cellular Infiltrate, Mononuclear Cell; Study_ID: R040729",Other,,
198,1016308,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Autolysis; Study_ID: R040729,Other,,
199,1016309,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Left Atrium, Fibrosis; Study_ID: R040729",Other,,
200,1016310,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Papillary Muscle, Myocyte, Degeneration; Study_ID: R040729",Other,,
201,1016311,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Right Ventricle, Cellular Infiltrate, Mononuclear Cell; Study_ID: R040729",Other,,
202,1016312,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Infiltrative Cell, Polymorphonuclear Cell; Study_ID: R040729",Other,,
203,1016313,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Infiltrative Cell, Mononuclear Cell; Study_ID: R040729",Other,,
204,1016314,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Cortex, Mineralization; Study_ID: R040729",Other,,
205,1016315,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Papilla, Tubule, Regeneration; Study_ID: R040729",Other,,
206,1016316,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Right Ventricle, Fibrosis; Study_ID: R040729",Other,,
207,1016317,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Medulla, Tubule, Dilatation; Study_ID: R040729",Other,,
208,1016318,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Nephropathy; Study_ID: R040729,Other,,
209,1016319,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Cellular Infiltrate, Mixed Cell; Study_ID: R040729",Other,,
210,1016320,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Left Atrium, Cellular Infiltrate, Mononuclear Cell; Study_ID: R040729",Other,,
211,1016321,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Right Ventricle, Myocyte, Degeneration; Study_ID: R040729",Other,,
212,1016322,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Right Ventricle, Myocyte, Lipid Accumulation; Study_ID: R040729",Other,,
213,1016323,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Interstitium, Inflammation, Chronic; Study_ID: R040729",Other,,
214,1018194,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Medulla, Mineralization; Study_ID: R040729",Other,,
215,1018195,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Papilla, Necrosis; Study_ID: R040729",Other,,
216,1018196,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Degeneration; Study_ID: R040729",Other,,
217,1018781,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Perivascular Edema; Study_ID: R040729",Other,,
218,1018782,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Single Hepatocyte Necrosis; Study_ID: R040729,Other,,
219,1018783,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Left Ventricle, Fibrosis; Study_ID: R040729",Other,,
220,1018784,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Papillary Muscle, Cellular Infiltrate, Mixed Cell; Study_ID: R040729",Other,,
221,1018785,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Right Atrium, Cellular Infiltrate, Mononuclear Cell; Study_ID: R040729",Other,,
222,1018786,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Cortex, Tubule, Vacuolation; Study_ID: R040729",Other,,
223,1018787,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Interstitium, Fibrosis; Study_ID: R040729",Other,,
224,1018788,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Papilla, Mineralization; Study_ID: R040729",Other,,
225,1018789,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Papilla, Cyst(S); Study_ID: R040729",Other,,
226,1018790,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Epicardium, Hyperplasia; Study_ID: R040729",Other,,
227,1018791,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Cellular Infiltrate, Mononuclear Cell; Study_ID: R040729",Other,,
228,1018792,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Necrosis, Fibrinoid; Study_ID: R040729",Other,,
229,1018793,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Perivascular Fibrosis; Study_ID: R040729",Other,,
230,1018794,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Nuclear Cytoplasmic Condensation; Study_ID: R040729,Other,,
231,1018795,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Cortex, Tubule, Dilatation; Study_ID: R040729",Other,,
232,1018796,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Left Ventricle, Cellular Infiltrate, Mononuclear Cell; Study_ID: R040729",Other,,
233,1018797,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Left Ventricle, Myocyte, Degeneration; Study_ID: R040729",Other,,
234,1018798,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Pelvis, Inflammation, Subacute; Study_ID: R040729",Other,,
235,1018799,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Pelvis, Urothelial Hyperplasia; Study_ID: R040729",Other,,
236,1018800,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Interventricular Septum, Cellular Infiltrate, Mononuclear Cell; Study_ID: R040729",Other,,
237,1018801,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Papillary Muscle, Cellular Infiltrate, Mononuclear Cell; Study_ID: R040729",Other,,
238,1018802,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Tubule, Deposit; Study_ID: R040729",Other,,
239,1018803,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Pelvis, Dilatation; Study_ID: R040729",Other,,
240,1018804,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Tubule, Hyaline Droplets; Study_ID: R040729",Other,,
241,1018805,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Cortex, Tubule, Necrosis; Study_ID: R040729",Other,,
242,1018806,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Endocardium, Cellular Infiltrate, Mononuclear Cell; Study_ID: R040729",Other,,
243,1018807,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Tunica Media, Hypertrophy; Study_ID: R040729",Other,,
244,1018808,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Cortex, Cyst(S); Study_ID: R040729",Other,,
245,1018809,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Left Atrium, Myocyte, Degeneration; Study_ID: R040729",Other,,
246,1018810,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Right Ventricle, Cellular Infiltrate, Mixed Cell; Study_ID: R040729",Other,,
247,1018811,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Medulla, Cyst(S); Study_ID: R040729",Other,,
248,1018812,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Tubule, Regeneration; Study_ID: R040729",Other,,
249,1018813,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Interventricular Septum, Cellular Infiltrate, Mixed Cell; Study_ID: R040729",Other,,
250,1018814,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Interventricular Septum, Fibrosis; Study_ID: R040729",Other,,
251,1018815,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Interventricular Septum, Myocyte, Degeneration; Study_ID: R040729",Other,,
252,1018816,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Left Ventricle, Cellular Infiltrate, Mixed Cell; Study_ID: R040729",Other,,
253,1018817,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 6 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Tubule, Cast, Proteinaceous; Study_ID: R040729",Other,,
254,1029830,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Epicardium, Cellular Infiltrate, Mixed Cell; Study_ID: R040729",Other,,
255,1029831,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Epicardium, Cellular Infiltrate, Mononuclear Cell; Study_ID: R040729",Other,,
256,1029832,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Autolysis; Study_ID: R040729,Other,,
257,1029833,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Left Atrium, Fibrosis; Study_ID: R040729",Other,,
258,1029834,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Papillary Muscle, Myocyte, Degeneration; Study_ID: R040729",Other,,
259,1029835,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Right Ventricle, Cellular Infiltrate, Mononuclear Cell; Study_ID: R040729",Other,,
260,1029836,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Infiltrative Cell, Polymorphonuclear Cell; Study_ID: R040729",Other,,
261,1029837,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Infiltrative Cell, Mononuclear Cell; Study_ID: R040729",Other,,
262,1029838,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Cortex, Mineralization; Study_ID: R040729",Other,,
263,1032290,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Papilla, Tubule, Regeneration; Study_ID: R040729",Other,,
264,1032291,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Right Ventricle, Fibrosis; Study_ID: R040729",Other,,
265,1032292,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Medulla, Tubule, Dilatation; Study_ID: R040729",Other,,
266,1032293,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Nephropathy; Study_ID: R040729,Other,,
267,1032294,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Cellular Infiltrate, Mixed Cell; Study_ID: R040729",Other,,
268,1032295,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Left Atrium, Cellular Infiltrate, Mononuclear Cell; Study_ID: R040729",Other,,
269,1032296,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Right Ventricle, Myocyte, Degeneration; Study_ID: R040729",Other,,
270,1032297,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Right Ventricle, Myocyte, Lipid Accumulation; Study_ID: R040729",Other,,
271,1032298,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Interstitium, Inflammation, Chronic; Study_ID: R040729",Other,,
272,1032299,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Medulla, Mineralization; Study_ID: R040729",Other,,
273,1032300,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Papilla, Necrosis; Study_ID: R040729",Other,,
274,1032301,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Tubule, Hyaline Droplets; Study_ID: R040729",Other,,
275,1032302,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Degeneration; Study_ID: R040729",Other,,
276,1032303,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Perivascular Edema; Study_ID: R040729",Other,,
277,1032304,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Single Hepatocyte Necrosis; Study_ID: R040729,Other,,
278,1032305,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Left Ventricle, Fibrosis; Study_ID: R040729",Other,,
279,1032306,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Papillary Muscle, Cellular Infiltrate, Mixed Cell; Study_ID: R040729",Other,,
280,1032307,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Right Atrium, Cellular Infiltrate, Mononuclear Cell; Study_ID: R040729",Other,,
281,1032308,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Cortex, Tubule, Vacuolation; Study_ID: R040729",Other,,
282,1032309,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Interstitium, Fibrosis; Study_ID: R040729",Other,,
283,1032310,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Papilla, Mineralization; Study_ID: R040729",Other,,
284,1032311,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Papilla, Cyst(S); Study_ID: R040729",Other,,
285,1032312,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Epicardium, Hyperplasia; Study_ID: R040729",Other,,
286,1032313,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Cellular Infiltrate, Mononuclear Cell; Study_ID: R040729",Other,,
287,1032314,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Necrosis, Fibrinoid; Study_ID: R040729",Other,,
288,1032315,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Perivascular Fibrosis; Study_ID: R040729",Other,,
289,1032316,1,3,,103581572,440917,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Nuclear Cytoplasmic Condensation; Study_ID: R040729,Other,,
290,1032317,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Cortex, Tubule, Dilatation; Study_ID: R040729",Other,,
291,1032318,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Left Ventricle, Cellular Infiltrate, Mononuclear Cell; Study_ID: R040729",Other,,
292,1032319,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Left Ventricle, Myocyte, Degeneration; Study_ID: R040729",Other,,
293,1032320,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Pelvis, Inflammation, Subacute; Study_ID: R040729",Other,,
294,1032321,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Pelvis, Urothelial Hyperplasia; Study_ID: R040729",Other,,
295,1032322,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Papillary Muscle, Cellular Infiltrate, Mononuclear Cell; Study_ID: R040729",Other,,
296,1032323,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Tubule, Deposit; Study_ID: R040729",Other,,
297,1032324,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Pelvis, Dilatation; Study_ID: R040729",Other,,
298,1032910,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Cortex, Tubule, Necrosis; Study_ID: R040729",Other,,
299,1032911,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Endocardium, Cellular Infiltrate, Mononuclear Cell; Study_ID: R040729",Other,,
300,1032912,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Tunica Media, Hypertrophy; Study_ID: R040729",Other,,
301,1032913,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Cortex, Cyst(S); Study_ID: R040729",Other,,
302,1032914,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Left Atrium, Myocyte, Degeneration; Study_ID: R040729",Other,,
303,1034007,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Right Ventricle, Cellular Infiltrate, Mixed Cell; Study_ID: R040729",Other,,
304,1034008,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Medulla, Cyst(S); Study_ID: R040729",Other,,
305,1034009,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Tubule, Regeneration; Study_ID: R040729",Other,,
306,1034010,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Interventricular Septum, Cellular Infiltrate, Mixed Cell; Study_ID: R040729",Other,,
307,1034011,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Interventricular Septum, Cellular Infiltrate, Mononuclear Cell; Study_ID: R040729",Other,,
308,1034012,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Interventricular Septum, Fibrosis; Study_ID: R040729",Other,,
309,1034013,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Interventricular Septum, Myocyte, Degeneration; Study_ID: R040729",Other,,
310,1034014,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Heart; Assay: Left Ventricle, Cellular Infiltrate, Mixed Cell; Study_ID: R040729",Other,,
311,1034015,1,3,,103581572,440917,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 4 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Kidney; Assay: Tubule, Cast, Proteinaceous; Study_ID: R040729",Other,,
312,1081538,1,1,,103581572,440917,Unspecified,,,,,Nematicidal activity against Meloidogyne incognita J2 (root-knot nematode) larvae immersed in compound solution for 24 hr assessed as reduction in larval motility,Other,20527965.0,
313,1081539,1,1,,103581572,440917,Unspecified,,,,,Nematicidal activity against Meloidogyne incognita J2 (root-knot nematode) larvae immersed in compound solution for 48 hr assessed as reduction in larval motility,Other,20527965.0,
314,1081540,1,1,,103581572,440917,Unspecified,,,,,Nematicidal activity against Meloidogyne incognita J2 (root-knot nematode) larvae immersed in compound solution for 96 hr assessed as reduction in larval motility,Other,20527965.0,
315,1082363,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Liposcelis bostrychophila (booklice) assessed as repellent activity at 1.6 nL/cm2 after 4 hr,Other,21819085.0,
316,1082364,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Liposcelis bostrychophila (booklice) assessed as repellent activity at 3.2 nL/cm2 after 4 hr,Other,21819085.0,
317,1082365,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Liposcelis bostrychophila (booklice) assessed as repellent activity at 6.4 nL/cm2 after 4 hr,Other,21819085.0,
318,1082366,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Liposcelis bostrychophila (booklice) assessed as repellent activity at 13 nL/cm2 after 4 hr,Other,21819085.0,
319,1082367,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Liposcelis bostrychophila (booklice) assessed as repellent activity at 26 nL/cm2 after 4 hr,Other,21819085.0,
320,1082368,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Liposcelis bostrychophila (booklice) assessed as repellent activity at 1.6 nL/cm2 after 2 hr,Other,21819085.0,
321,1082369,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Liposcelis bostrychophila (booklice) assessed as repellent activity at 3.2 nL/cm2 after 2 hr,Other,21819085.0,
322,1082370,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Liposcelis bostrychophila (booklice) assessed as repellent activity at 6.4 nL/cm2 after 2 hr,Other,21819085.0,
323,1082371,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Liposcelis bostrychophila (booklice) assessed as repellent activity at 13 nL/cm2 after 2 hr,Other,21819085.0,
324,1082372,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Liposcelis bostrychophila (booklice) assessed as repellent activity at 26 nL/cm2 after 2 hr,Other,21819085.0,
325,1082373,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Tribolium castaneum (red flour beetle) assessed as repellent activity at 0.0016 nL/cm2 after 4 hr,Other,21819085.0,
326,1082374,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Tribolium castaneum (red flour beetle) assessed as repellent activity at 0.016 nL/cm2 after 4 hr,Other,21819085.0,
327,1082375,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Tribolium castaneum (red flour beetle) assessed as repellent activity at 0.16 nL/cm2 after 4 hr,Other,21819085.0,
328,1082376,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Tribolium castaneum (red flour beetle) assessed as repellent activity at 1.6 nL/cm2 after 4 hr,Other,21819085.0,
329,1082377,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Tribolium castaneum (red flour beetle) assessed as repellent activity at 16 nL/cm2 after 4 hr,Other,21819085.0,
330,1082378,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Tribolium castaneum (red flour beetle) assessed as repellent activity at 0.016 nL/cm2 after 2 hr,Other,21819085.0,
331,1082379,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Tribolium castaneum (red flour beetle) assessed as repellent activity at 0.0016 nL/cm2 after 2 hr,Other,21819085.0,
332,1082380,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Tribolium castaneum (red flour beetle) assessed as repellent activity at 0.16 nL/cm2 after 2 hr,Other,21819085.0,
333,1082381,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Tribolium castaneum (red flour beetle) assessed as repellent activity at 1.6 nL/cm2 after 2 hr,Other,21819085.0,
334,1082382,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Tribolium castaneum (red flour beetle) assessed as repellent activity at 16 nL/cm2 after 2 hr,Other,21819085.0,
335,1098230,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against Sitophilus granarius (granary weevil) assessed as mortality,Other,23731643.0,
336,1098239,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Leptinotarsa decemlineata infested potato leaves assessed as mortality at 20 ul after 96 hr relative to control,Other,23731643.0,
337,1098240,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Leptinotarsa decemlineata infested potato leaves assessed as mortality at 20 ul after 48 hr relative to control,Other,23731643.0,
338,1098241,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Leptinotarsa decemlineata infested potato leaves assessed as mortality at 20 ul after 24 hr relative to control,Other,23731643.0,
339,1098242,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Leptinotarsa decemlineata infested potato leaves assessed as mortality at 20 ul after 12 hr relative to control,Other,23731643.0,
340,1098243,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Leptinotarsa decemlineata infested potato leaves assessed as mortality at 10 ul after 96 hr relative to control,Other,23731643.0,
341,1098244,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Leptinotarsa decemlineata infested potato leaves assessed as mortality at 10 ul after 48 hr relative to control,Other,23731643.0,
342,1098245,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Leptinotarsa decemlineata infested potato leaves assessed as mortality at 10 ul after 24 hr relative to control,Other,23731643.0,
343,1098246,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against adult Leptinotarsa decemlineata infested potato leaves assessed as mortality at 10 ul after 12 hr relative to control,Other,23731643.0,
344,1098263,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against third-instar larval stage of Leptinotarsa decemlineata infested potato leaves assessed as mortality at 20 ul after 96 hr (Rvb = 3.3 +/- 3.3%),Other,23731643.0,
345,1098264,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against third-instar larval stage of Leptinotarsa decemlineata infested potato leaves assessed as mortality at 20 ul after 48 hr (Rvb = 3.3 +/- 3.3%),Other,23731643.0,
346,1098265,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against third-instar larval stage of Leptinotarsa decemlineata infested potato leaves assessed as mortality at 20 ul after 24 hr relative to control,Other,23731643.0,
347,1098266,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against third-instar larval stage of Leptinotarsa decemlineata infested potato leaves assessed as mortality at 20 ul after 12 hr relative to control,Other,23731643.0,
348,1098267,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against third-instar larval stage of Leptinotarsa decemlineata infested potato leaves assessed as mortality at 10 ul after 96 hr (Rvb = 3.3 +/- 3.3%),Other,23731643.0,
349,1098268,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against third-instar larval stage of Leptinotarsa decemlineata infested potato leaves assessed as mortality at 10 ul after 48 hr (Rvb = 3.3 +/- 3.3%),Other,23731643.0,
350,1098269,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against third-instar larval stage of Leptinotarsa decemlineata infested potato leaves assessed as mortality at 10 ul after 24 hr relative to control,Other,23731643.0,
351,1098270,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against third-instar larval stage of Leptinotarsa decemlineata infested potato leaves assessed as mortality at 10 ul after 12 hr relative to control,Other,23731643.0,
352,1098295,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against second-instar larval stage of Leptinotarsa decemlineata infested potato leaves assessed as mortality at 20 ul after 96 hr (Rvb = 3.3 +/- 3.3%),Other,23731643.0,
353,1098296,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against second-instar larval stage of Leptinotarsa decemlineata infested potato leaves assessed as mortality at 20 ul after 48 hr (Rvb = 3.3 +/- 3.3%),Other,23731643.0,
354,1098297,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against second-instar larval stage of Leptinotarsa decemlineata infested potato leaves assessed as mortality at 20 ul after 24 hr (Rvb = 3.3 +/- 3.3%),Other,23731643.0,
355,1098298,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against second-instar larval stage of Leptinotarsa decemlineata infested potato leaves assessed as mortality at 20 ul after 12 hr relative to control,Other,23731643.0,
356,1098299,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against second-instar larval stage of Leptinotarsa decemlineata infested potato leaves assessed as mortality at 10 ul after 96 hr (Rvb = 3.3 +/- 3.3%),Other,23731643.0,
357,1098300,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against second-instar larval stage of Leptinotarsa decemlineata infested potato leaves assessed as mortality at 10 ul after 48 hr (Rvb = 3.3 +/- 3.3%),Other,23731643.0,
358,1098301,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against second-instar larval stage of Leptinotarsa decemlineata infested potato leaves assessed as mortality at 10 ul after 24 hr (Rvb = 3.3 +/- 3.3%),Other,23731643.0,
359,1098302,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against second-instar larval stage of Leptinotarsa decemlineata infested potato leaves assessed as mortality at 10 ul after 12 hr relative to control,Other,23731643.0,
360,1098311,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against first-instar larval stage of Leptinotarsa decemlineata infested potato leaves assessed as mortality at 20 ul after 96 hr relative to control,Other,23731643.0,
361,1098312,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against first-instar larval stage of Leptinotarsa decemlineata infested potato leaves assessed as mortality at 20 ul after 48 hr relative to control,Other,23731643.0,
362,1098313,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against first-instar larval stage of Leptinotarsa decemlineata infested potato leaves assessed as mortality at 20 ul after 24 hr relative to control,Other,23731643.0,
363,1098314,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against first-instar larval stage of Leptinotarsa decemlineata infested potato leaves assessed as mortality at 20 ul after 12 hr relative to control,Other,23731643.0,
364,1098315,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against first-instar larval stage of Leptinotarsa decemlineata infested potato leaves assessed as mortality at 10 ul after 96 hr relative to control,Other,23731643.0,
365,1098316,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against first-instar larval stage of Leptinotarsa decemlineata infested potato leaves assessed as mortality at 10 ul after 48 hr relative to control,Other,23731643.0,
366,1098317,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against first-instar larval stage of Leptinotarsa decemlineata infested potato leaves assessed as mortality at 10 ul after 12 hr relative to control,Other,23731643.0,
367,1098318,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against first-instar larval stage of Leptinotarsa decemlineata infested potato leaves assessed as mortality at 10 ul after 24 hr relative to control,Other,23731643.0,
368,1111942,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against abamectin-resistant female Tetranychus urticae ART-53 (two-spotted spider mite) in kidney bean assessed as mortality in 3 cm disks measured after 24 hr exposure by vapour-phase mortality bioassay,Other,21674753.0,
369,1111943,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against pyridaben-resistant female Tetranychus urticae PRT-53 (two-spotted spider mite) in kidney bean assessed as mortality in 3 cm disks measured after 24 hr exposure by vapour-phase mortality bioassay,Other,21674753.0,
370,1111944,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against fenpropathrin-resistant female Tetranychus urticae FRT-53 (two-spotted spider mite) in kidney bean assessed as mortality in 3 cm disks measured after 24 hr exposure by vapour-phase mortality bioassay,Other,21674753.0,
371,1111945,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against chlorfenapyr-resistant female Tetranychus urticae CRT-53 (two-spotted spider mite) in kidney bean assessed as mortality in 3 cm disks measured after 24 hr exposure by vapour-phase mortality bioassay,Other,21674753.0,
372,1111946,1,1,,103581572,440917,Unspecified,,,,,Insecticidal activity against acaricide-susceptible female Tetranychus urticae KST (two-spotted spider mite) in kidney bean assessed as mortality in 3 cm disks measured after 24 hr exposure by vapour-phase mortality bioassay,Other,21674753.0,
373,1112517,1,1,,103581572,440917,Unspecified,,,,,Toxicity to Musca domestica (house fly) applied to pronotum assessed as compound level per fly causing insect mortality measured after 24 hr,Other,22461383.0,
374,1112518,1,4,,103581572,440917,Unspecified,74919269.0,101900690.0,,,Displacement of [3H]TBOB binding to GABA receptor in Musca domestica (house fly) heads homogenates assessed as [3H]TBOB binding at 500 uM incubated for 90 min by scintillation counting method,Other,22461383.0,
375,1127228,1,1,,103581572,440917,Unspecified,,,,GI50,Growth inhibition of human U251 cells after 48 hrs by sulforhodamine B assay,Confirmatory,24727464.0,
376,1127229,1,1,,103581572,440917,Inconclusive,,,,GI50,Growth inhibition of human UACC62 cells after 48 hrs by sulforhodamine B assay,Confirmatory,24727464.0,
377,1127230,1,1,,103581572,440917,Unspecified,,,,GI50,Growth inhibition of human MCF7 cells after 48 hrs by sulforhodamine B assay,Confirmatory,24727464.0,
378,1127231,1,1,,103581572,440917,Unspecified,,,,GI50,Growth inhibition of human NCI-ADR-RES cells after 48 hrs by sulforhodamine B assay,Confirmatory,24727464.0,
379,1127232,1,1,,103581572,440917,Unspecified,,,,GI50,Growth inhibition of human NCI-H460 cells after 48 hrs by sulforhodamine B assay,Confirmatory,24727464.0,
380,1127233,1,1,,103581572,440917,Unspecified,,,,GI50,Growth inhibition of human 786-0 cells after 48 hrs by sulforhodamine B assay,Confirmatory,24727464.0,
381,1127234,1,1,,103581572,440917,Unspecified,,,,GI50,Growth inhibition of human PC3 cells after 48 hrs by sulforhodamine B assay,Confirmatory,24727464.0,
382,1127235,1,1,,103581572,440917,Unspecified,,,,GI50,Growth inhibition of human OVCAR3 cells after 48 hrs by sulforhodamine B assay,Confirmatory,24727464.0,
383,1127236,1,1,,103581572,440917,Unspecified,,,,GI50,Growth inhibition of human HT-29 cells after 48 hrs by sulforhodamine B assay,Confirmatory,24727464.0,
384,1127237,1,1,,103581572,440917,Unspecified,,,,GI50,Growth inhibition of human K562 cells after 48 hrs by sulforhodamine B assay,Confirmatory,24727464.0,
385,1127238,1,1,,103581572,440917,Unspecified,,,,GI50,Growth inhibition of African green monkey Vero cells after 48 hrs by sulforhodamine B assay,Confirmatory,24727464.0,
386,1159509,1,1,,144207598,440917,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
387,1159515,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
388,1159516,1,1,,144207598,440917,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
389,1159517,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
390,1159518,1,1,,144207598,440917,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
391,1159519,1,1,,144207598,440917,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
392,1159520,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
393,1159521,1,1,,144207598,440917,Inactive,15928672.0,19885.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
394,1159523,1,1,,144207598,440917,Inactive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
395,1159525,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
396,1159526,1,1,,144207598,440917,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
397,1159527,1,1,,144207598,440917,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
398,1159528,1,1,,144207598,440917,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
399,1159529,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
400,1159531,1,1,,144207598,440917,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
401,1159551,1,1,,144207598,440917,Inconclusive,,,27.2783,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
402,1159552,1,1,,144207598,440917,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
403,1159553,2,1,,144207598,440917,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
404,1159555,1,1,,144207598,440917,Inconclusive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
405,1176195,1,1,,103581572,440917,Active,,,,,Antiasthmatic activity in ovalbumin-sensitized BALB/c mouse allergy model assessed as reduction in BAL aldehyde level compound treated at 4 g through inhalation prior to ovalbumin challenge,Other,25499435.0,
406,1176196,1,1,,103581572,440917,Active,,,,,Antiasthmatic activity in ovalbumin-sensitized BALB/c mouse allergy model assessed as reduction in lung aldehyde level compound treated at 4 g through inhalation prior to ovalbumin challenge,Other,25499435.0,
407,1176197,1,2,,103581572,440917,Active,,,,,Antiasthmatic activity in ovalbumin-sensitized BALB/c mouse allergy model assessed as reduction in spleen tissue aldehyde level compound treated at 4 g through inhalation prior to ovalbumin challenge,Other,25499435.0,
408,1176198,1,1,,103581572,440917,Unspecified,,,,,Antiasthmatic activity in ovalbumin-sensitized BALB/c mouse allergy model assessed as reduction in neutrophil count compound treated at 4 g through inhalation prior to ovalbumin challenge (Rvb = 43.1 /mm3),Other,25499435.0,
409,1176199,1,1,,103581572,440917,Unspecified,,,,,Antiasthmatic activity in ovalbumin-sensitized BALB/c mouse allergy model assessed as reduction in eosinophil count compound treated at 4 g through inhalation prior to ovalbumin challenge (Rvb = 11 /mm3),Other,25499435.0,
410,1176200,1,1,,103581572,440917,Unspecified,,,,,Antiasthmatic activity in ovalbumin-sensitized BALB/c mouse allergy model assessed as reduction in peribronchial inflammatory cell infiltration compound treated at 4 g through inhalation prior to ovalbumin challenge by hematoxylin eosin staining method relative to control,Other,25499435.0,
411,1176201,1,1,,103581572,440917,Unspecified,,,,,Antiasthmatic activity in ovalbumin-sensitized BALB/c mouse allergy model assessed as reduction in perivascular inflammatory cell infiltration compound treated at 4 g through inhalation prior to ovalbumin challenge by hematoxylin eosin staining method relative to control,Other,25499435.0,
412,1176202,1,1,,103581572,440917,Unspecified,,,,,Antiasthmatic activity in ovalbumin-sensitized BALB/c mouse allergy model assessed as reduction in occlusion of the airway diameter by mucus compound treated at 4 g through inhalation prior to ovalbumin challenge by hematoxylin eosin staining method relative to control,Other,25499435.0,
413,1176203,1,1,,103581572,440917,Unspecified,,,,,Antiasthmatic activity in ovalbumin-sensitized BALB/c mouse allergy model assessed as reduction in epithelial cell mucus metaplasia compound treated at 4 g through inhalation prior to ovalbumin challenge by hematoxylin eosin staining method relative to control,Other,25499435.0,
414,1176204,1,1,,103581572,440917,Unspecified,,,,,Antiasthmatic activity in ovalbumin-sensitized BALB/c mouse allergy model assessed as reduction in sub-epithelial fibrosis compound treated at 4 g through inhalation prior to ovalbumin challenge by hematoxylin eosin staining method relative to control,Other,25499435.0,
415,1224834,3,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
416,1224835,1,1,,144207598,440917,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
417,1224836,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
418,1224837,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
419,1224838,1,1,,144207598,440917,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
420,1224839,1,1,,144207598,440917,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
421,1224840,3,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
422,1224841,3,1,,144207598,440917,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
423,1224842,3,1,,144207598,440917,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
424,1224843,1,1,,144207598,440917,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
425,1224844,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
426,1224845,1,1,,144207598,440917,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
427,1224846,1,1,,144207598,440917,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
428,1224847,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
429,1224848,3,1,,144207598,440917,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
430,1224849,3,1,,144207598,440917,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
431,1224867,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
432,1224868,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
433,1224869,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
434,1224870,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
435,1224871,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
436,1224872,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
437,1224873,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
438,1224874,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
439,1224875,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
440,1224876,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
441,1224877,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
442,1224878,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
443,1224879,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
444,1224880,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
445,1224881,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
446,1224882,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
447,1224883,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
448,1224884,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
449,1224885,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
450,1224886,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
451,1224887,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
452,1224888,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
453,1224889,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
454,1224890,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
455,1224892,1,1,,144207598,440917,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
456,1224893,1,1,,144207598,440917,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
457,1224894,1,1,,144207598,440917,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
458,1224895,1,1,,144207598,440917,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
459,1224896,1,1,,144207598,440917,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
460,1259241,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
461,1259242,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
462,1259243,1,1,,144207598,440917,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
463,1259244,1,1,,144207598,440917,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
464,1259247,1,1,,144207598,440917,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
465,1259248,1,1,,144207598,440917,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
466,1259364,1,1,,144207598,440917,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
467,1259365,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
468,1259366,1,1,,144207598,440917,Inconclusive,,,61.0684,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
469,1259367,1,1,,144207598,440917,Inconclusive,,,48.5084,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
470,1259368,1,1,,144207598,440917,Inactive,109731339.0,2737.0,48.5084,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
471,1259369,1,1,,144207598,440917,Inconclusive,109731339.0,2737.0,1.2185,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
472,1259377,1,1,,144207598,440917,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
473,1259378,1,1,,144207598,440917,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
474,1259379,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
475,1259380,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
476,1259381,1,1,,144207598,440917,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
477,1259382,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
478,1259383,1,1,,144207598,440917,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
479,1259384,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
480,1259385,1,1,,144207598,440917,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
481,1259386,1,1,,144207598,440917,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
482,1259387,1,1,,144207598,440917,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
483,1259388,1,1,,144207598,440917,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
484,1259390,1,1,,144207598,440917,Inconclusive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
485,1259391,1,1,,144207598,440917,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
486,1259392,1,1,,144207598,440917,Inconclusive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
487,1259393,1,1,,144207598,440917,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
488,1259394,1,1,,144207598,440917,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
489,1259395,1,1,,144207598,440917,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
490,1259396,1,1,,144207598,440917,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
491,1259401,1,1,,144207598,440917,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
492,1259402,1,1,,144207598,440917,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
493,1259403,1,1,,144207598,440917,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
494,1259404,1,1,,144207598,440917,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
495,1259407,1,1,,363898621,440917,Inactive,,,,,CCRIS mutagenicity studies,Other,,
496,1259409,1,1,,363898621,440917,Unspecified,,,,,CCRIS tumor inhibitor studies,Other,,
497,1259410,1,1,,363898621,440917,Unspecified,,,,,CCRIS tumor promotion studies,Other,,
498,1259411,1,1,,363898621,440917,Inactive,,,,,CCRIS carcinogenicity studies,Other,,
